Crimson Life Sciences
Medical Device Labeling Survey by Crimson Life Sciences Exposes Serious Translation Risks
Published in Medical Letter on the CDC and FDA, April 12th, 2009
Crimson Life Sciences, a division of TransPerfect, announced the results of a two-year audit survey designed to measure the risks associated with labeling translation for device manufacturers. The comprehensive analysis spans 21 languages, dozens of labeling audits, and over a million translated words. Crimson’s audit survey found that the average “serious error rate” was 400% higher than the serious error rate associated with the current industry best practice. A serious translation error is one that may result in patient harm.
According to Crimson President, Marc H. Miller, “These results suggest that many manufacturers have substantial liability and recall risks...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cancer
Ezetimibe and Ezetimibe/Simvastatin Combo Pose No Increased Cancer Risk, Study Shows - Cell Therapy
Scientists at Medical College of Georgia, Medical College report research in cell therapy - Depression
Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents - Kidneys
New kidneys study findings have been published by scientists at Food & Drug Administration - Life Sciences
New life sciences study findings have been reported by researchers at University of California - Life Sciences
Recent studies by R.R. Ratan and co-authors add new data to life sciences findings - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
